ADAshmita Debnath

Ashmita Debnath

*This is an algorithmically generated author record based on publicly available information.

Ashmita Debnath has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immuno‐Targeting of CLRN3 and SCAMP1 as a Potential Sex Specific Marker in Bovine Spermatozoa

    by Ashmita Debnath, Hemanth Kumar Pundla, Kaivalya Deshmukh, Vineet Kumar Pandey, Neeraj Srivastava, Ajay Kumar, Karuna Irungbam, Subrata Kumar Ghosh, S. K. Singh, Mukesh Kumar, et al.

    Sex‐specific proteins are unique markers found on either X‐ or Y‐chromosome bearing spermatozoa, acting like molecular signatures, and can be used as a key target to distinguish X‐ or Y‐bearing cells. Towards this goal, by reviewing the literature, a total of 6 proteins were selected from the selected, of which 2, CLRN3 and SCAMP1, were finally chosen for the immunoprecipitation study. For the finally selected proteins, predictions of subcellular localisation and transmembrane topology were generated using online tools such as BUSCA, DeepLoc 2.0, DeepTMHMM, and TMHMM. Additionally, several online platforms like SEMMA 2.0 and IEDB were employed to identify potential immunogenic targets. Following this, commercially available antibodies against the 2 identified proteins were procured for subsequent use in multiple immunoprecipitation‐based techniques, such as Western blotting, immunocytochemistry, and ELISA (Enzyme‐linked immunosorbent assay). Targeting these proteins revealed their binding intensity on spermatozoa. In this study, the CLRN3 antibody targeting X‐spermatozoa showed stronger interaction with X‐sorted samples than the Y‐specific SCAMP1 antibody in the cell‐based ELISA. Results from the study suggest targeting sex‐specific surface proteins could enable the development of an immune‐based sperm‐sorting technique in bovines. Overall, the results support the potential of CLRN3 as an X‐specific surface marker that needs further validation for the development of a novel immune‐based sperm sorting technique.

  • Emerging Proteomic Approaches in Sperm Sorting: Shaping the Future of Reproductive Biotechnology

    by Ashmita Debnath, Hemanth Kumar Pundla, Kaivalya Deshmukh, Vineet Kumar Pandey, Neeraj Srivastava, Dharmesh Goswami, Subrata Kumar Ghosh, S. K. Singh, Bhanu Prakash, Sujatha Lakshmi Narayanan, et al.

    Sperm sexing is a prominent Assisted Reproductive Technology (ART) that enhances reproductive efficiency, boosts production and improves the economic viability of dairy farms. To meet the growing demand for milk and dairy products, improvements in genetic selection and breeding strategies are imperative. Towards this goal, the use of sex‐sorted semen enables the preferential production of female calves, thereby directly contributing to faster genetic gain, increased milk yield, and an optimised herd structure. At present, the commercially available and widely adopted sperm sexing technique is flow cytometry, offering up to 90% sorting accuracy based on the difference in DNA content. However, its widespread application is limited due to high operational costs, technical complexity, and potential adverse effects on sperm viability and fertility. Recent advancements in proteomics and immunological methods have opened new avenues for developing cost‐effective, non‐invasive sperm‐sorting technologies. Such approaches are designed to enhance sorting efficiency, maintain sperm integrity, and offer methods that can be effectively implemented on a larger scale to meet breeders' requirements. This review discusses the current status, technological limitations, regulatory frameworks, and future prospects of proteomic and immune‐based strategies in bovine sperm sexing, with a focus on their potential to transform flexible bovine productivity at large.

  • Open Access

    Curcumin as a Potential Hypoglycaemic Agent for Managing Oxidative Stress

    by Ashmita Debnath, M. A. Ali, Kaivalya Deshmukh, Ajoy Das, Longjam Shantabi, Shrilla Elangbam

    This review outlined the basic mechanisms by which curcumin exerted protective effects in diabetes and discussed its potential as a supportive treatment for oxidative stress-related metabolic disorders. Curcumin, a yellow compound from the rhizomes of Curcuma longa, the primary active ingredient in turmeric. It was a lipophilic polyphenol, a bis-a, b-unsaturated b-diphenone, with the chemical formula C21H20O6 and the name (E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione. This plant had several biological properties like antimicrobial, anti-inflammatory etc and one of which included anti-diabetic property as well. Diabetes mellitus was a metabolic disorder that has reached pandemic proportions world-wide. As the incidence of type 2 diabetes mellitus (T2DM) continues to rise globally, oxidative stress and inflammation have emerged as major drivers of its progression and complications. Oxidative stress plays a crucial role as one of the major causes of diabetes, as it leads to the destruction of pancreatic beta cells and a consequent lack of insulin production. Therefore, curcumin contributed to redox balance by enhancing the activity of endogenous antioxidant systems through the Nrf2-ARE signalling pathway and limiting inflammatory responses via inhibition of NF-κB. Additionally, it supported glucose regulation by improving insulin sensitivity, promoting glucose uptake, and reducing hepatic glucose production. Despite these promising effects, curcumin’s therapeutic use was challenged by its poor oral bioavailability, leading to exploration of advanced delivery strategies including nanoparticles, liposomal encapsulation, and phytosome formulations.